Allarity Lawsuit Submission Form | Securities Class Action Lawyers

Return to Home

Allarity Therapeutics, Inc.

ALLR

Find Out if You Qualify for a Financial Reward by filling out the form below.

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Owned

Purchase Date

Estimated Loss

Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Allarity disclosed on July 22, 2024, that it received a Wells Notice from the SEC concerning “the Company’s disclosures regarding meetings with the United States Food and Drug Administration (the “FDA”) regarding the Company’s NDA for Dovitinib or Dovitinib-DRP, which was submitted to the FDA in 2021.” On this news, the price of the Company’s stock dropped.

Find More Cases

Ticker Symbol	Company Name	Join Deadline
IOVA	Iovance Biotherapeutics, Inc.	July 14, 2025	Join
OGN	Organon & Co.	July 22, 2025	Join
VSTS	Vestis Corporation	August 08, 2025	Join
RCKT	Rocket Pharmaceuticals, Inc.	August 11, 2025	Join
CNC	Centene Corporation	September 08, 2025	Join

Allarity Therapeutics, Inc.

ALLR

Allarity Therapeutics, Inc. Form

Find More Cases